Krónikus gyulladásos demielinizációs polineuropátia (CIDP): vizsgálatok itt: Dánia
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 19.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Aarhus N, Copenhagen Oe
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - 3. fázisTaking peopleA Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Where
- Copenhagen Oe
- Életkor
- 18 év and over
- People
- 218 worldwide
- Run by
- argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Where
- Copenhagen Oe
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00 - 2. fázisTaking peopleImeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Copenhagen Oe, Odense C
- Életkor
- 18 év and over
- People
- 162 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07032662 · EU 2024-517614-14-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Aarhus, Copenhagen
- Életkor
- 18 év to 75 év
- People
- 256 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT06858579 - 3. fázisCsak meghívásosLong-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Where
- Aarhus, Copenhagen
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Aarhus N, Copenhagen Oe
- Életkor
- 18 év and over
- People
- 138 worldwide
- Run by
- Dianthus Therapeutics Inc.
See details and how to join2024-517529-26-00 - 3. fázisTaking peopleA Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Where
- Aarhus N, Copenhagen Oe
- Életkor
- 18 év and over
- People
- 59 worldwide
- Run by
- Takeda
See details and how to joinNCT06747351 · EU 2024-517450-95-00 - No phaseTaking peopleA Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Where
- Aarhus N, København Ø
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Takeda
See details and how to joinNCT06538064 · EU 2024-512690-26-00 - 4. fázisBefejeződöttSubcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
- Where
- Aalborg, Aarhus N, Copenhagen Oe, Odense C
- Életkor
- 18 év and over
- People
- 60
- Run by
- University of Aarhus
See details and how to joinNCT04589299 · EU 2024-515898-96-01